Phibro Animal Health (PAHC) Gross Profit (2012 - 2026)

Phibro Animal Health's Gross Profit history runs 15 years deep, the most recent figure standing at $125.7 million for Q1 2026.

• In Q1 2026, Gross Profit rose 20.18% year-over-year to $125.7 million; the TTM figure through Mar 2026 stood at $488.1 million (up 29.45% YoY), while the FY2025 annual figure was $399.9 million, up 27.74% from the prior year.
• Gross Profit for Q1 2026 stood at $125.7 million, down from $132.7 million in the prior quarter.
• The five-year high for Gross Profit was $132.7 million in Q4 2025, with the low at $67.7 million in Q3 2023.
• The 5-year median for Gross Profit is $79.6 million (2024), against an average of $90.6 million.
• The sharpest annual moves came in 2023 and 2025: Gross Profit declined 2.24% in 2023, then jumped 43.46% in 2025.
• Phibro Animal Health's Gross Profit stood at $77.4 million in 2022, then climbed by 1.59% to $78.6 million in 2023, then grew by 29.58% to $101.9 million in 2024, then jumped by 30.22% to $132.7 million in 2025, then decreased by 5.26% to $125.7 million in 2026.
• Business Quant data shows PAHC's Gross Profit at $125.7 million in Q1 2026, $132.7 million in Q4 2025, and $119.8 million in Q3 2025.